Endovascular simulation at Transcatheter Cardiovascular Therapeutics symposium

13 October 2008

Medical Simulation Corporation (MSC) has teamed up with Boston Scientific Corporation (BSC) to provide product- and procedure-based simulation experiences aboard two BSC Mobile Simulation Labs to attendees of the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Physician, nurse and technologist attendees interested in an introduction to endovascular simulation, or looking to advance their skills using an endovascular simulator, are invited to visit the BSC Mobile Simulation Labs for a hands-on session. Attendees may select from a number of introductory to advanced cases that are either procedure-based or product-based.

Visit the Mobile Simulation Labs in the Physician Training Center
Lower Level: Halls A, B and C,
Tuesday, October 14 – Thursday, October 16, 9 a.m. – 5 p.m.

MSC procedural courses include Carotid, Iliac, SFA and Renal Interventions. Product courses include High Risk Coronary Lesions (featuring the BSC Rotablator Rotational Atherectomy System) and Complex Saphenous Vein Graft Lesions (featuring the BSC FilterWire EZTM Embolic Protection System).

“MSC is proud to partner with Boston Scientific to provide high-fidelity simulation to enhance BSC’s product marketing and sales goals,” says Bill Younkes, MSC President. “Through the unique mobile delivery platform, the BSC SimSuite program has successfully created a highly-recognizable industry brand that successfully delivers experience-based training programs to physicians and their teams across the country.”

Symposium website: http://www.tctconference.com/
Walter E. Washington Convention Center; Washington, DC

Bookmark this page
Del.icio.us  Reddit  StumbleUpon 

To top